Solange M F Ribeiro

Title: Solange M F Ribeiro: Innovator in Kidney Disease Treatment

Introduction

Solange M F Ribeiro is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical research, particularly in the treatment of kidney diseases. His innovative approach focuses on the use of peptides to improve renal function and reduce renal damage.

Latest Patents

Ribeiro holds a patent titled "Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease." This invention provides a method for treating kidney or renal diseases by administering a pharmaceutically effective amount of a purified LAP peptide, a TSP-1 type 1 repeat peptide, or a fragment thereof. The goal is to interfere with the activation process of TGF-β by thrombospondin-1, thereby reducing and preventing renal damage. Additionally, the invention aims to improve renal function in subjects with impaired renal function.

Career Highlights

Solange M F Ribeiro is associated with the UAB Research Foundation at the University of Alabama at Birmingham. His work has been instrumental in advancing the understanding and treatment of kidney-related conditions. With a focus on innovative therapeutic methods, Ribeiro continues to contribute to the medical field.

Collaborations

Ribeiro has collaborated with esteemed colleagues such as Joanne Murphy-Ullrich and Christian Hugo. These partnerships have enhanced the research and development of his innovative approaches to kidney disease treatment.

Conclusion

In summary, Solange M F Ribeiro is a pioneering inventor whose work in kidney disease treatment through peptide technology showcases his commitment to medical innovation. His contributions are vital in the ongoing quest to improve renal health and patient outcomes.